Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Sean Parker launches cancer institute
by Lisa M. Jarvis
April 18, 2016
| A version of this story appeared in
Volume 94, Issue 16
The foundation started by tech billionaire Sean Parker is putting up $250 million to create the Parker Institute for Cancer Immunotherapy, which will support 300 researchers across six academic cancer centers. The institute plans to develop cell-based therapies, expand the number of patients who benefit from checkpoint therapies, and find tumor antigen targets that could lead to cancer vaccines. Any intellectual property it generates will be licensed or spun off into a company, with proceeds being divided between the institute and the six academic sites.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter